Optimizing the production of animal models for target and lead validation

Drug Discovery Today: TARGETS

Volumn 1, Issue 3, 2002, Pages 109-116

  Fogarty, Patrick ^a  

^a Tosk Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; RECOMBINANT DNA;

DNA TRANSFECTION; DRUG INDUSTRY; GENE DELIVERY SYSTEM; GENE INSERTION SEQUENCE; GENE REPLACEMENT THERAPY; GENE TARGETING; GENE TECHNOLOGY; GENE VECTOR; GENETIC ENGINEERING; HETEROZYGOTE; KNOCKOUT MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PROGENY; REVIEW; STRUCTURAL HOMOLOGY; TRANSGENIC ANIMAL; TRANSGENICS; TRANSPOSON; VALIDATION PROCESS;

EID: 15744382263     PISSN: 17418372     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1477-3627(02)02198-0     Document Type: Review

References (15)

1. Model Organisms for Drug Discovery (2002) IBC Conference August 8-9, Boston, MA
2. Spradling, A.C. et al. (1995) Gene disruptions using P transposable elements: an integral component of the Drosophila genome project. Proc. Natl. Acad. Sci. U. S. A. 92, 10824-10830
3. Ivics, Z. et al. (1997) Molecular reconstruction of Sleeping Beauty, a Tel-like transposon from fish, and its transposition in human cells. Cell 91, 501-510
4. Luo, G. et al. (1998) Chromosomal transposition of a Tcl/mariner-like element in mouse embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 95, 10769-10773
5. Dupuy, A.J. et al. (2002) Mammalian germ-line transgenesis by transposition. Proc. Natl. Acad. Sci. U. S. A. 99, 4495-4499
6. Yant, S.R. et al. (2000) Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat. Genet. 25, 35-41
7. Fogarty, P. and Lipsick, J. (2001) P element derived vector and methods for its use. September 18, United States Patent No. 6,291,243
8. Kuzminov, A. (2001) DNA replication meets genetic exchange: chromosomal damage and its repair by homologous recombination. Proc. Natl. Acad. Sci. U. S. A. 98, 8461-8468
9. Aratani, Y. et al. (1992) End extension repair of introduced targeting vectors mediated by homologous recombination in mammalian cells. Nucleic Acids Res. 20, 4795-4801
10. Wakeland, E. et al. (1997) Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol. Today 18, 472-477
11. Paylor, R. et al. (1994) DBA/2 and C57BL/6 mice differ in contextual fear but not auditory fear conditioning. Behav. Neurosci. 108, 810-817
12. Dockstader, C.L. and van der Kooy, D. (2001) Mouse strain differences in opiate reward learning are explained by differences in anxiety, not reward or learning. J. Neurosci. 21, 9077-9081
13. Hicks, G.G. et al. (1997) Functional genomics in mice by tagged sequence mutagenesis. Nat. Genet. 16, 338-344
14. Zambrowicz, B.P. et al. (1998) Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells. Nature 392, 608-611
15. Abuin, A. et al. (2002) Full-speed mammalian genetics: in vivo target validation in the drug discovery process. Trends Biotechnol. 20, 36-42